Insider · CIK 0001821432
Catherine Coste
director
Files at BMRA (BIOMERICA INC), BLFS (BIOLIFE SOLUTIONS INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | BLFS BIOLIFE SOLUTIONS INC | DDisposition to issuer Common Stock | -13,871 | - | - | 0 | 4 d ago |
| Mar 18, 2025 | BLFS BIOLIFE SOLUTIONS INC | AGrant or award Common Stock | +5,701 | - | - | 5,701 | Mar 20, 2025 |
| Dec 13, 2024 | BMRA BIOMERICA INC | AGrant or award Common stock | +85,000 | $0.31 | $26k | 128,790 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.